Twist Bioscience Corp (NASDAQ:TWST) shares, rose in value, with the stock price up by 1.48% to the previous day’s close as strong demand from buyers drove the stock to $31.54.
Actively observing the price movement in the last trading, the stock closed the session at $31.08. Referring to stock’s 52-week performance, its high was $43.21, and the low was $11.46. On the whole, TWST has fluctuated by -8.53% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 293.24M, with a low estimate of 70M and a high estimate of 72.1M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 70.65M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TWST’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of TWST currently trading nearly 0.61% and -9.58% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 48.35, while the 7-day volatility ratio is showing 5.48% which for the 30-day chart, stands at 4.87%. Furthermore, Twist Bioscience Corp (TWST)’s beta value is 1.64, and its average true range (ATR) is 1.70.
A comparison of Twist Bioscience Corp (TWST) with its peers suggests the former has fared considerably weaker in the market. TWST showed an intraday change of 1.48% in last session, and over the past year, it grew by 151.11%%.
Data on historical trading for Twist Bioscience Corp (NASDAQ:TWST) indicates that the trading volumes over the past 3 months, they’ve averaged 900.58K. According to company’s latest data on outstanding shares, there are 57.56 million shares outstanding.
Nearly 4.36% of Twist Bioscience Corp’s shares belong to company insiders and institutional investors own 113.63% of the company’s shares. The stock has fallen by -14.43% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TWST stock heading into the next quarter.
